Barely Significant
← all excerpts

Multiple Benefits of Empagliflozin in PCOS: Evidence from a Preclinical Rat Model.

Pathophysiology · 2024 · PMC11503319 · PMID 39449523

2
hedged sentences
closest p
boldest claim

The sentences

a positive trendno p-value reported
Group P exhibited the highest increase in body weight, while other treatment groups also showed a positive trend in body weight gain, though they were not statistically significant.

also in 11,005 other papers

However, in a study on systolic blood pressure, the EMPA-treated group did not reach statistical significance compared to the non- treated PCOS group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.